Evidence map›Paper›PMID 27539266›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2016

Use of a Novel Nonparametric Version of DEPTH to Identify Genomic Regions Associated with Prostate Cancer Risk.

Robert J MacInnis, Daniel F Schmidt, Enes Makalic, Gianluca Severi, Liesel M FitzGerald, Matthias Reumann, Miroslaw K Kapuscinski, Adam Kowalczyk, Zeyu Zhou, Benjamin Goudey and 11 more

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Using DEPendency of Association on the Number of Top Hits (DEPTH) as a Complementary Tool to Identify Novel Colorectal Cancer Susceptibility Loci.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Robert J MacInnisCancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia.
Daniel F SchmidtCentre for Epidemiology and Biostatistics, University of Melbourne, Melbourne, Australia.
Enes MakalicCentre for Epidemiology and Biostatistics, University of Melbourne, Melbourne, Australia.
Gianluca SeveriHuman Genetics Foundation, Torino, Italy.
Liesel M FitzGeraldMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania.
Matthias ReumannIBM Research, Zurich, Switzerland.
Miroslaw K KapuscinskiCentre for Epidemiology and Biostatistics, University of Melbourne, Melbourne, Australia.
Adam KowalczykWarsaw University of Technology, Warsaw, Poland.
Zeyu ZhouIBM Research - Australia, Carlton, Australia.
Benjamin GoudeyIBM Research - Australia, Carlton, Australia.
Guoqi QianSchool of Mathematics and Statistics, University of Melbourne, Parkville, Victoria, Australia.
Quang M BuiCentre for Epidemiology and Biostatistics, University of Melbourne, Melbourne, Australia.
Daniel J ParkGenetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Victoria, Australia.
Adam FreemanCentre for Epidemiology and Biostatistics, University of Melbourne, Melbourne, Australia.
Melissa C SoutheyGenetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Victoria, Australia.
Ali Amin Al OlamaCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Zsofia Kote-JaraiThe Institute of Cancer Research, London, United Kingdom.
Rosalind A Eeles
John L HopperCentre for Epidemiology and Biostatistics, University of Melbourne, Melbourne, Australia. j.hopper@unimelb.edu.au.
Graham G GilesCancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia.
UK Genetic Prostate Cancer Study Collaborators

Funding

Epidemiological and Clinical Translational Studies Post Genome-Wide AssociationU19CA148537 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI EASTON, DOUGLAS FREDERICK, EELES, ROSALIND · 2010 to 2014
$10.4M
Cancer Research UK 15007Cancer Research UK 17528NCI NIH HHS U19 CA148537
6 · The paper itself

Abstract

backgroundWe have developed a genome-wide association study analysis method called DEPTH (DEPendency of association on the number of Top Hits) to identify genomic regions potentially associated with disease by considering overlapping groups of contiguous markers (e.g., SNPs) across the genome. DEPTH is a machine learning algorithm for feature ranking of ultra-high dimensional datasets, built from well-established statistical tools such as bootstrapping, penalized regression, and decision trees. Unlike marginal regression, which considers each SNP individually, the key idea behind DEPTH is to rank groups of SNPs in terms of their joint strength of association with the outcome. Our aim was to compare the performance of DEPTH with that of standard logistic regression analysis.

methodsWe selected 1,854 prostate cancer cases and 1,894 controls from the UK for whom 541,129 SNPs were measured using the Illumina Infinium HumanHap550 array. Confirmation was sought using 4,152 cases and 2,874 controls, ascertained from the UK and Australia, for whom 211,155 SNPs were measured using the iCOGS Illumina Infinium array.

resultsFrom the DEPTH analysis, we identified 14 regions associated with prostate cancer risk that had been reported previously, five of which would not have been identified by conventional logistic regression. We also identified 112 novel putative susceptibility regions.

conclusionsDEPTH can reveal new risk-associated regions that would not have been identified using a conventional logistic regression analysis of individual SNPs. IMPACT: This study demonstrates that the DEPTH algorithm could identify additional genetic susceptibility regions that merit further investigation. Cancer Epidemiol Biomarkers Prev; 25(12); 1619-24. ©2016 AACR.

Indexed as

Genetic Predisposition to DiseaseMachine LearningPolymorphism, Single NucleotideAustraliaGenome-Wide Association StudyHumansMaleMiddle AgedProstatic NeoplasmsUnited Kingdom

Identifiers

PMID27539266
PMCPMC5232414

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.